STEMCELL Technologies Wins Support from Western Innovation (WINN) Initiative

STEMCELL Technologies has received $949,500 in repayable assistance from the Western Innovation (WINN) Initiative for an exciting project to develop tools and assays for three-dimensional (3D) cell culture.

Led by Dr. Steven Woodside, Director of Particle Chemistry and Engineering, and Dr. Eric Jervis, Principal Scientist, the project builds on STEMCELL Technologies’ extensive experience in developing culture systems and specialized cell culture media for life science research.

3D cell culture better mirrors the environment experienced by cells in the body, and so provides improved physiological relevance for many areas of research and drug development, including cancer research, cell therapy, drug screening, toxicity testing and tissue/organ engineering.

The development of convenient and robust 3D culture systems is critical to these important fields. Studies based on 3D culture are more predictive of disease states and drug responses, and enable more mechanistically accurate modelling of the target tissue.

Commenting on the award, Dr. Allen Eaves, CEO and President of STEMCELL Technologies stated: “We are thrilled to have received the support of the Western Innovation Initiative and are confident the project will accelerate life science research and facilitate the development of novel drug formulations.”